/ Merck
/ Market Analysis
Why Is Moderna (MRNA) Stock Up Today: Merck Partnered Vaccine Cuts Recurrence Risk
Moderna stock rose over 7% after the company and Merck said their personalized melanoma vaccine kept working at five years, cutting recurrence or death risk by ...
January 21, 2026
Merck’s Stock Rises Amid New Cancer Treatment Drug Breakthrough
MSD's new injectable Keytruda formulation offers similar effectiveness to the intravenous version, potentially halving treatment time.
March 28, 2025
Big Pharma Stocks: Who’s Leading the Race and Who’s Slipping?
Merck's wider drug moat and acquisition spree makes it a safer bet but VKTX can be the next LLY.
August 20, 2024
Three Solid Stocks That Still Have Plenty of Growth Left
Which companies are positioned for greater growth?
November 20, 2023
Back to 
